Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Orexin System for Prescription Opioid Use Disorder
Alessandra Matzeu, Rémi Martin‐Fardon
Brain Sciences (2020) Vol. 10, Iss. 4, pp. 226-226
Open Access | Times Cited: 22

Showing 22 citing articles:

Heterogeneity in the Paraventricular Thalamus: The Traffic Light of Motivated Behaviors
Jacqueline F. McGinty, James M. Otis
Frontiers in Behavioral Neuroscience (2020) Vol. 14
Open Access | Times Cited: 61
Sleep dysregulation in binge eating disorder and “food addiction”: the orexin (hypocretin) system as a potential neurobiological link
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
Morgan H. James, Gary Aston‐Jones
Biological Psychiatry (2022) Vol. 92, Iss. 11, pp. 836-844
Open Access | Times Cited: 33
Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone
Martin A. Katzman, Matthew P. Katzman
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 150-150
Open Access | Times Cited: 30
Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
A review of physiological functions of orexin: From instinctive responses to subjective cognition
LiBo Xia, Haiyan Liu, Bi Yan Wang, et al.
Medicine (2023) Vol. 102, Iss. 26, pp. e34206-e34206
Open Access | Times Cited: 14
Neurotransmitters crosstalk and regulation in the reward circuit of subjects with behavioral addiction
Zhenlei Peng, Qiyu Jia, Junxiong Mao, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
A review of symptom, pathogenesis and treatment characteristics of the elderly with chronic insomnia
LiBo Xia, Haiyan Liu, Jixiang Ren
Medicine (2025) Vol. 104, Iss. 5, pp. e41346-e41346
Open Access
Forced Wheel Running Pre-Conditioning Diminishes Reward Learning Induced by Methamphetamine: Involvement of Orexin 1 Receptor in the Hippocampus
Mansoureh Ahmadpour, Shaghayegh Modaberi, Abbas Haghparast, et al.
Physiology & Behavior (2025), pp. 114892-114892
Closed Access
Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem
Mike Ufer, Debra Kelsh, Kerri A. Schoedel, et al.
SLEEP (2021) Vol. 45, Iss. 3
Open Access | Times Cited: 31
Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19
Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse
Ying Han, Lu Cao, Kai Yuan, et al.
Neuroscience Bulletin (2022) Vol. 38, Iss. 11, pp. 1365-1382
Open Access | Times Cited: 19
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Physiological Role of Orexin/Hypocretin in the Human Body in Motivated Behavior: A Comprehensive Review
Rahul Singh, Dalia Biswas
Cureus (2023)
Open Access | Times Cited: 9
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
Mark K. Greenwald, Tabitha E.H. Moses, Timothy Roehrs
Translational research (2021) Vol. 234, pp. 58-73
Open Access | Times Cited: 20
A retinal contribution to opioid-induced sleep disorders?
Nikolas Bergum, Casey-Tyler Berezin, József Vı́gh
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 4
Drug addiction co-morbidity with alcohol: Neurobiological insights
M. Adrienne McGinn, Caroline B. Pantazis, Brendan J. Tunstall, et al.
International review of neurobiology (2021), pp. 409-472
Closed Access | Times Cited: 5
Improving Sleep to Address Co-Occurring Substance Use Disorder and Chronic Pain: Exploring the Potential of the Orexin (Hypocretin) System as a Clinical Target
Chung Jung Mun, Matthew J. Reid, Sarah Sarandos, et al.
Current Addiction Reports (2024)
Closed Access
Brain Regions and Neurotransmitter Systems Involved in Stress-Induced Analgesia
farzaneh Nazari-Srenjeh, Zahra Ghasemzadeh
The Neuroscience Journal of Shefaye Khatam (2024) Vol. 13, Iss. 1, pp. 104-115
Open Access
緩和的放射線治療とメサドンによるがん疼痛緩和後にオピオイド中止により離脱症状を呈した1例
Ayaka Ishikawa, Sayaka Arakawa, Hiroto Ishiki, et al.
Palliative Care Research (2023) Vol. 18, Iss. 3, pp. 159-163
Open Access
The Orexin System, Prescription Opioid Use Disorder, and Orexin Receptors Blockade
Alessandra Matzeu, Rémi Martin‐Fardon
Springer eBooks (2022), pp. 1-17
Closed Access
The Orexin System, Prescription Opioid Use Disorder, and Orexin Receptors Blockade
Alessandra Matzeu, Rémi Martin‐Fardon
Springer eBooks (2022), pp. 1769-1785
Closed Access
Page 1

Scroll to top